IL-33 drives biphasic IL-13 production for noncanonical Type 2 immunity against hookworms. - Wikidata - awgldk - TriplyDB

IL-33 drives biphasic IL-13 production for noncanonical Type 2 immunity against hookworms.

IL-33 drives biphasic IL-13 production for noncanonical Type 2 immunity against hookworms.

http://www.wikidata.org/entity/Q36512087

about

IL-33 signaling is essential to attenuate viral-induced encephalitis development by downregulating iNOS expression in the central nervous system The Differentiation of CD4(+) T-Helper Cell Subsets in the Context of Helminth Parasite Infection Protection and pathology during parasite infection: IL-10 strikes the balance Innate lymphoid cells, possible interaction with microbiota ST2 deficiency does not impair type 2 immune responses during chronic filarial infection but leads to an increased microfilaremia due to an impaired splenic microfilarial clearance Immune antibodies and helminth products drive CXCR2-dependent macrophage-myofibroblast crosstalk to promote intestinal repair Immunity to gastrointestinal nematodes: mechanisms and myths Type-2 innate lymphoid cells control the development of atherosclerosis in mice Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells.Dusp5 negatively regulates IL-33-mediated eosinophil survival and function Systemic impact of intestinal helminth infections.Crucial and diverse role of the interleukin-33/ST2 axis in infectious diseases.Interleukin-33 in Tissue Homeostasis, Injury, and Inflammation Aspirin-Exacerbated Respiratory Disease Involves a Cysteinyl Leukotriene-Driven IL-33-Mediated Mast Cell Activation Pathway IL-33-Induced Cytokine Secretion and Survival of Mouse Eosinophils Is Promoted by Autocrine GM-CSF Upregulation of interleukin-33 and thymic stromal lymphopoietin levels in the lungs of idiopathic pulmonary fibrosis IL-33 Signaling Protects from Murine Oxazolone Colitis by Supporting Intestinal Epithelial Function.Intrinsic functional defects of type 2 innate lymphoid cells impair innate allergic inflammation in promyelocytic leukemia zinc finger (PLZF)-deficient mice.Myeloid-Restricted AMPKα1 Promotes Host Immunity and Protects against IL-12/23p40-Dependent Lung Injury during Hookworm Infection.Cytokine and chemokine responses to helminth and protozoan parasites and to fungus and mite allergens in neonates, children, adults, and the elderly.Hallmarks of Tissue-Resident Lymphocytes.IL-33 regulates the IgA-microbiota axis to restrain IL-1α-dependent colitis and tumorigenesis A tissue checkpoint regulates type 2 immunity.Role of the IL-33-ST2 axis in sepsis.Development of CD4 T Cell Dependent Immunity Against N. brasiliensis Infection Innate lymphoid cells and allergic inflammation.Host protective roles of type 2 immunity: parasite killing and tissue repair, flip sides of the same coin.Helminths in the lungs.Priming dendritic cells for th2 polarization: lessons learned from helminths and implications for metabolic disorders.Group 2 innate lymphoid cells in health and disease.New dog and new tricks: evolving roles for IL-33 in type 2 immunity.ILC2s and T cells cooperate to ensure maintenance of M2 macrophages for lung immunity against hookworms.Group 2 innate lymphoid cells in disease.Early Postnatal Secondhand Smoke Exposure Disrupts Bacterial Clearance and Abolishes Immune Responses in Muco-Obstructive Lung Disease.Interleukin 33: an innate alarm for adaptive responses beyond Th2 immunity-emerging roles in obesity, intestinal inflammation, and cancer.Airway epithelial dual oxidase 1 mediates allergen-induced IL-33 secretion and activation of type 2 immune responses.Roles of basophils and mast cells in cutaneous inflammation.Regulation of the host immune system by helminth parasites.Molecular events by which dendritic cells promote Th2 immune protection in helmith infection.Interleukin-33 in health and disease.

P2860

Q26700067-EABC0C9D-522B-4AE2-9B98-0FAAE1087AD4 Q26866318-6EFA456F-881B-4720-9411-9E085DC712A9 Q27005837-15DCA795-0AA4-441E-A9A1-F39A846A4EEE Q27026229-2AE24D61-D71A-4B3F-A3F6-339BDB898E53 Q27312578-A08AE814-3766-4C9F-9A41-A9A6C0493E83 Q27320551-9B3E1120-D5A2-4E0E-8E81-57FD5136381A Q28242288-952B0637-652C-4259-A7C7-BCC024853C5A Q33786641-30C26991-EEB1-4C62-88ED-547F20462F48 Q34442444-B9170AA4-3AA9-4381-BC25-D16912DF7750 Q35109566-B889E774-FA82-4304-A603-3F06944EBF63 Q35148851-FFB67283-6324-4B5C-BD18-A4E9B5D51213 Q35439783-BFB5F6F6-0426-4596-BA8B-85E8A8CED15D Q35754479-BF330A57-899B-48D1-9A0A-B7E15969657F Q36119388-002A19D6-1D3F-4D17-9A66-7E066F0E248F Q36150043-F83421B5-2C76-42CE-A70A-F91E13163270 Q36281721-1925DDA6-94D1-4F40-9958-2EDA3B650CD5 Q36303477-566880AA-B2D0-49A5-AF40-FE54492D28B0 Q36563630-06027C9B-0769-4ED2-92E5-BF463EA60A3C Q36923660-5B7992C6-41EF-4DF1-9A4E-E1F06E36ED7E Q37038054-68DB3483-D04E-46D1-9959-A3F77A71807E Q37152701-609D5D61-444E-46F1-AE3C-676C670061C9 Q37452192-E1C1A328-B92A-43CA-B9E0-4CB426C31180 Q37611447-B42A5B85-B05E-486F-A6AA-AE057B27A411 Q37620811-65FBA1AF-6E7B-4EFD-9A42-3784AA0F9E3F Q38091898-2CEB653F-C036-4716-A290-C2DBACB5487D Q38133877-D6452576-C701-437F-8F9C-A1526950564F Q38229984-5BCF877C-EA65-4932-811E-6ED1C3B4B77E Q38247210-1CBF1B35-8D15-4366-9E7E-EA9683BA1D6B Q38264905-8234778C-46C5-440D-9848-5114504E4D57 Q38312434-293317FB-E994-40E7-8C70-80F6497EEE56 Q38388349-07901318-ED1D-4F53-89BC-49903DF1887C Q38415097-E2A653A3-9E1F-48CD-8992-3C774EE2BC35 Q38573631-A0C96573-0D5B-4785-87F2-7772D642DE09 Q38699312-D5E85FD5-CA1D-44E0-A174-5F7AA2C40161 Q38783993-488BAB82-EAA8-48C1-823B-7641E094C506 Q38817497-2F41EEBE-F945-4D1B-B2EC-3EDA0FF07DBD Q38832477-36B990AA-97CB-4229-B596-7ED75B25569D Q38835948-1A2BE95F-4150-49A2-A09E-81528D5C5248 Q38878574-7DB00CB1-CFFE-41D7-BA5E-46075853A7CD Q38957840-1AA6CB24-7AD0-436F-834A-67B88ED4F74F

P2860

IL-33 drives biphasic IL-13 production for noncanonical Type 2 immunity against hookworms.

http://www.wikidata.org/entity/Q36512087

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

IL-33 drives biphasic IL-13 pr ...... 2 immunity against hookworms.

@ast

IL-33 drives biphasic IL-13 pr ...... 2 immunity against hookworms.

@en

type

label

IL-33 drives biphasic IL-13 pr ...... 2 immunity against hookworms.

@ast

IL-33 drives biphasic IL-13 pr ...... 2 immunity against hookworms.

@en

prefLabel

IL-33 drives biphasic IL-13 pr ...... 2 immunity against hookworms.

@ast

IL-33 drives biphasic IL-13 pr ...... 2 immunity against hookworms.

@en

P1433

Q36512087-2A849B1C-86D2-4A16-A2F5-FA3DDFBB336F

P1476

Q36512087-B35F5F9A-9F08-40B0-9D8C-DDFF8C863C3E

P2093

Q36512087-11AAF911-31BE-4834-8578-7D7E0CCCEEC5

Q36512087-54CEE5D6-4A05-4678-A86F-23888A5E3D3A

Q36512087-768C2A32-D3BA-412A-9DDD-0886BC2836C8

Q36512087-925E2485-3493-4D2B-8E39-4EDE056D97B9

Q36512087-BF04BE1C-03A4-430C-8F22-B8172ADCA232

Q36512087-C16C5779-99EF-42DA-A6E4-5277ABF5B267

Q36512087-D1868E23-5315-4B1F-AD1E-8A8316AE9BE4

P2860

Q36512087-09EDEE4C-31FE-45A4-8734-82F1B6FAB7E4

Q36512087-0E040315-677A-4767-9375-081F946A8716

Q36512087-0E80B5E5-3927-4701-97AA-D879141F5F1C

Q36512087-1297773A-E4E9-44D5-A37F-420798193694

Q36512087-137CB880-A725-4D07-B3E7-DE59D7D7E215

Q36512087-17C463D2-47C5-47B8-B909-E03ADF8891D1

Q36512087-1F07DDB6-B12D-4A49-8B51-F276D818F0E4

Q36512087-2496AFDD-84A6-4692-9E46-72BB7F7DABF6

Q36512087-271C2DCC-D582-4B5F-AC3F-580BF3709A12

Q36512087-34FA2FE3-F123-4C85-971F-05938F08B22D

P304

Q36512087-49AE5932-4159-4C72-93F8-0CDBAA4ECDB1

P31

Q36512087-64ED65C2-48BC-4DB6-AADD-ED585DCA1699

P356

Q36512087-F779392C-48D2-4BC2-B5A6-57488A28CAB0

P407

Q36512087-C4B79752-85B5-4673-9D2E-2FDAAD16C974

P433

Q36512087-2329BD14-D565-43D7-937E-E1093506EC7A

P478

Q36512087-66BBD9AB-65CB-46C7-BB1B-85E90C0BB401

P577

Q36512087-DCA76D53-4D86-4127-97D5-FFCDBD405B93

P5875

Q36512087-A014B791-EDEB-43BE-B7BA-B577FD9D09E3

P698

Q36512087-AF3D5993-F43D-4F87-9AC8-35FC6C4D48E7

P932

Q36512087-ADDFD2E6-CD79-4946-B553-B57792CB33FB

P356

PNAS.1206587110

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

IL-33 drives biphasic IL-13 pr ...... 2 immunity against hookworms.

@en

P2093

De'Broski R Herbert

http://www.w3.org/2001/XMLSchema#string

Dirk E Smith

http://www.w3.org/2001/XMLSchema#string

Ian P Lewkowich

http://www.w3.org/2001/XMLSchema#string

Jordan Downey

http://www.w3.org/2001/XMLSchema#string

Li-Yin Hung

http://www.w3.org/2001/XMLSchema#string

Lucas A Dawson

http://www.w3.org/2001/XMLSchema#string

Yanfen Yang

http://www.w3.org/2001/XMLSchema#string

P2860

Systemically dispersed innate IL-13-expressing cells in type 2 immunity

Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity

IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G

A novel IL-1 family cytokine, IL-33, potently activates human eosinophils

Human hookworm infection in the 21st century

Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion

Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm

IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex

IL-33, a potent inducer of adaptive immunity to intestinal nematodes

Intestinal epithelial cell secretion of RELM-beta protects against gastrointestinal worm infection.

P304

282-287

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1206587110

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

110

http://www.w3.org/2001/XMLSchema#string

P577

2012-12-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233941923

http://www.w3.org/2001/XMLSchema#string

P698

23248269

http://www.w3.org/2001/XMLSchema#string

P932

3538196

http://www.w3.org/2001/XMLSchema#string